Felippini, Arturo; Biglia, Luiza Vasconcelos; Lima, Tácio de Mendonça 
; Aguiar, Patrícia Melo
Fonte: Health Policy. Unidade: FCF
Assuntos: DOENÇAS RARAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FELIPPINI, Arturo et al. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review. Health Policy, v. 144, p. 1-8 art. 105080, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.healthpol.2024.105080. Acesso em: 12 out. 2024.APA
Felippini, A., Biglia, L. V., Lima, T. de M., & Aguiar, P. M. (2024). HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review. Health Policy, 144, 1-8 art. 105080. doi:10.1016/j.healthpol.2024.105080NLM
Felippini A, Biglia LV, Lima T de M, Aguiar PM. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review [Internet]. Health Policy. 2024 ; 144 1-8 art. 105080.[citado 2024 out. 12 ] Available from: https://dx.doi.org/10.1016/j.healthpol.2024.105080Vancouver
Felippini A, Biglia LV, Lima T de M, Aguiar PM. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review [Internet]. Health Policy. 2024 ; 144 1-8 art. 105080.[citado 2024 out. 12 ] Available from: https://dx.doi.org/10.1016/j.healthpol.2024.105080
